Participants
Contact
“Correo Farmacéutico” gives news about a donation of 200,00 US$ from the North American association FARA for the gene therapy project devoted to Friedreich’s ataxia developed at IRB and CBM Severo Ochoa.
This project has been promoted from various patients’ associations headed by Genefa.
Read the news in “Correo Farmacéutico” (PDF)
Related news:
28 January 2014
International patient advocates partner to fund Spanish gene-therapy project to treat Friedreich's ataxia
14 November 2013
Patients and scientists join forces to tackle Friedreich’s Ataxia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
